PofoliaShared via Pofolia

Ocular Immunology and Inflammation· 2026Q2

Bilateral Vaso-Occlusive Retinopathy Unmasking Primary Antiphospholipid Syndrome in a Child

Samah Mbarek, Olfa Blel, Amina Marghli, Nada Sakli et al.

Short summary

A 12-year-old girl presented with severe bilateral vaso-occlusive retinopathy, leading to the diagnosis of primary pediatric antiphospholipid syndrome (APS) as the initial manifestation.

AI-generated from the title and abstract; the full text is not read.

Key points

  • A 12-year-old girl presented with severe bilateral vaso-occlusive retinopathy as the initial symptom.
  • The retinopathy led to the diagnosis of primary pediatric antiphospholipid syndrome (APS).
  • Multimodal imaging revealed peripheral vascular sheathing, neovascularization, and retinal detachment.
  • Treatment involved a multidisciplinary approach including corticosteroids, plasmapheresis, anticoagulation, and panretinal photocoagulation.

AI-generated from the title and abstract; the full text is not read.

Abstract

Purpose To report a rare case of primary pediatric antiphospholipid syndrome (APS) presenting with severe bilateral vaso-occlusive retinopathy as the initial manifestation, and to discuss its diagnostic and therapeutic implications.Methods We report the clinical presentation, multimodal imaging findings, systemic work-up, and management of a 12-year-old girl with bilateral vaso-occlusive retinopathy as the presenting feature of primary antiphospholipid syndrome.Results A 12-year-old girl with no prior medical history presented with incidentally detected visual loss in the left eye. Best-corrected visual acuity (BCVA) was 20/50 in the right eye (RE) and no light perception in the left eye (LE). Fundus examination revealed peripheral vascular sheathing and preretinal neovascularization in the RE, and tractional retinal detachment in the LE. Fluorescein angiography (FA) demonstrated extensive areas of peripheral non perfusion in the RE and fibrovascular proliferation in the LE. The diagnosis of primary pediatric APS was established based on the persistent positivity of lupus anticoagulant in the absence of an underlying autoimmune disorder. A multidisciplinary approach was adopted, involving ophthalmologists, pediatricians, and neurologists. The patient received intravenous corticosteroids, plasmapheresis, systemic anticoagulation (low-molecular-weight heparin bridged to warfarin), and panretinal photocoagulation in both eyes. At 18 months of follow-up, BCVA in the RE improved to 20/20, with neovascular regression on FA. The LE, however, progressed to total tractional retinal detachment.Conclusion Primary pediatric APS may initially present with devastating bilateral vaso-occlusive retinopathy. Early recognition through systematic antiphospholipid antibody testing and prompt multidisciplinary management are essential for preserving vision.

The authors' abstract, as published at the source. Ocular Immunology and Inflammation, 2026 · DOI ↗

TakeawaysIn the app
Ask the paperIn the app

The rest is in the Pofolia app

Takeaways and questions to the paper; new summaries every day for your field. Free.

Sign in on the web to open

Field: Rheumatology

RheumatologyMedicine